First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
Published Online: 2021-01-?
Journal: The Lancet•Publisher: Elsevier BV
Authors: Aaron S Mansfield•Abderrahim Oukessou•Anna K Nowak•Anne S Tsao•Arnaud Scherpereel•Christine Baudelet•Dariusz Kowalski•Francesco Grossi•Gérard Zalcman•Jerónimo Rodríguez-Cid•Laurent Greillier•Nobukazu Fujimoto•Paul Baas•Praveen Aanur•Robin Cornelissen•Sanjay Popat•Scott Antonia•Solange Peters•Thierry Jahan•Yolanda Bautista•Youssef Oulkhouir
